A meta-analysis of published studies was performed in order to clarify the risk of gastric cancer associated with cigarette smoking status.
Methods
Eligible studies were all the case-control studies investigating an association between smoking status and gastric cancer published from January 1, 1997, until June 30, 2006. In order to evaluate the quality of the published data, a qualitative scoring of papers was applied. The principal outcome measure was the odds ratio for the risk of gastric cancer associated with the smoking status using a random effects model. Cigarette smoking status was assessed in two ways: ever (current and ex) versus never smokers; current versus never smokers.
Results
We found a statistically significant result for the association between ever smoking status and gastric cancer risk (OR = 1.48; 95% CI, 1.28–1.71), considering 14,442 cases and 73,918 controls. Moreover, we found an odds ratio of 1.69 for current smoker status in comparison to never smokers (95% CI, 1.35–2.11). Considering only high quality studies, the odds ratio increased by 43% for gastric cancer risk in ever smokers (OR = 1.43; 95% CI, 1.24–1.66; Q = 378.60, P <0.00001; I2 = 90%) and by 57% in current smokers (OR = 1.57; 95% CI, 1.24–2.01). We also considered separately Caucasians and Asian studies, finding for ever smokers an odds ratio of 1.46 (95% CI, 1.25–1.70; Q = 125.68, P <0.00001; I2 = 82.5%) and of 1.47 (95% CI, 1.13–1.91; Q = 366.77, P <0.00001; I2 = 94%), respectively.
Conclusions
From the results of this quantitative meta-analysis, it appears that cigarette smoking has to be considered an important risk factor. The use of qualitative scoring decreases the magnitude of the relationship both for ever and current smoker exposure by 5–12%. Future studies on this topic need to clarify the biological interaction between environmental factors (such as cigarette smoking) and different polymorphisms on gastric cancer.
ParkinD.M.: International variation. Oncogene, 23: 6329–6340, 2004.
2.
VerdecchiaA., MariottoA., GattaG., Bustamante-TeixeiraM.T., AjikiW.: Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer, 39: 1603–1609, 2003.
3.
GoekkurtE., HoehnS., WolschkeC., WittmerC., StueberC., HossfeldD.K., StoehlmacherJ.: Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients. Br J Cancer, 94: 281–286, 2006.
4.
CorreaP., SchneiderB.G.: Etiology of gastric cancer: what is new?Cancer Epidemiol Biomarkers Prev, 14: 1865–1868, 2005.
5.
LaTorreG., BocciaS., RicciardiG.: Glutathione S-Transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett, 217: 53–60, 2005.
6.
BocciaS., La TorreG., GianfagnaF., MannocciA., RicciardiG.: Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis, 21: 115–123, 2006.
7.
KahnH.A.: The Dorn study of smoking and mortality among US veterans: report on 8.5 years of observation. Natl Cancer Inst Monogr, 19: 1–125, 1996.
8.
HammondE.C.: Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr, 19: 127–204, 1996.
9.
TredanielJ., BoffettaP., BuiattiE., SaracciR., HirschA.: Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer, 72: 565–573, 1997.
10.
RothmanK.J., GreenlandS.: Modern epidemiology, Second edn, Lippincott-Raven, Philadelphia, 1998.
11.
McLaughlinJ.K., MandelJ.S., MehlE.S., BlotW.J.: Comparison of next-of-kin with self-respondents regarding questions on cigarette, coffee, and alcohol consumption. Epidemiology, 1: 408–412, 1990.
12.
DeVitoC., ManzoliL., MarzuilloC., AnastasiD., BocciaA., VillariP.: A systematic review evaluating the potential for bias and the methodological quality of meta-analyses in vaccinology. Vaccine, 25: 8794–8806, 2007.
13.
DerSimonianR., LairdN.: Meta-analysis in clinical trials. Control Clin Trials, 7: 177–188, 1986.
14.
Review Manager (RevMan) [Computer program]: Version 4.2 for Windows.Oxford: The Cochrane Collaboration; 2002.
15.
BocciaS., PersianiR., La TorreG., RauseiS., ArzaniD., GianfagnaF., Romano-SpicaV., D'UgoD., RicciardiG.: Sulfo-transferase 1A1 polymorphism and gastric cancer risk: a pilot case-control study. Cancer Lett, 229: 235–243, 2005.
16.
KimD.S., LeeM.S., KimY.S., KimD.H., BaeJ.M., ShinM.H., AhnY.O.: Effect modification by vitamin C on the relation between gastric cancer and Helicobacter pylori. Eur J Epidemiol, 20: 67–71, 2005.
17.
LiH., ChenX.L., LiH.Q.: Polymorphism of CYPIA1 and GSTM1 genes associated with susceptibility of gastric cancer in Shandong Province of China. World J Gastroenterol, 11: 5757–5762, 2005.
18.
LindbladM., RodriguezL.A., LagergrenJ.: Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control, 16: 285–294, 2005.
19.
LuW., PanK., ZhangL., LinD., MiaoX., YouW.: Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor a and risk of gastric cancer in a Chinese population. Carcinogenesis, 26: 631–636, 2005.
20.
MuL.N., LuQ.Y., YuS.Z., JiangQ.W., CaoW., YouN.C., SetiawanV.W., ZhouX.F., DingB.G., WangR.H., ZhaoJ., CaiL., RaoJ.Y., HeberD., ZhangZ.F.: Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer, 116: 972–983, 2005.
21.
NanH.M., SongY.J., YunH.Y., ParkJ.S., KimH.: Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer. World J Gastroenterol, 11: 3834–3841, 2005.
22.
PhukanR.K., ZomawiaE., NarainK., HazarikaN.C., MahantaJ.: Tobacco use and stomach cancer in Mizoram, India. Cancer Epidemiol Biomarkers Prev, 14: 1892–1896, 2005.
23.
RousseauM.C., ParentM.E., SiemiatyckiJ.: Comparison of self-reported height and weight by cancer type among men from Montreal, Canada. Eur J Cancer Prev, 14: 431–438, 2005.
24.
SetiawanV.W., YuG.P., LuQ.Y., LuM.L., YuS.Z., MuL., ZhangJ.G., KurtzR.C., CaiL., HsiehC.C., ZhangZ.F.: Allium vegetables and stomach cancer risk in China. Asian Pac J Cancer Prev, 6: 387–395, 2005.
25.
ShenJ., WangR.T., XuY.C., WangL.W., WangX.R.: Interaction models of CYP1A1, GSTM1 polymorphisms and tobacco smoking in intestinal gastric cancer. World J Gastroenterol, 11: 6056–6060, 2005.
26.
SulJ., YuG.P., LuQY., LuM.L., SetiawanV.W., WangM.R., GuoC.H., YuS.Z., MuL., CaiL., KurtzR.C., ZhangZ.F.: P53 Codon 72 polymorphisms: A case-control study of gastric cancer and potential interactions. Cancer Lett, 238: 210–223, 2006.
27.
TamerL., AtesN.A., AtesC., ErcanB., ElipekT., YildirimH., CamdevirenH., AtikU., AydinS.: Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct, 23: 267–272, 2005.
28.
ZhangZ., XuY., ZhouJ., WangX., WangL., HuX., GuoJ., WeiQ., ShenH.: Polymorphisms of thymidylate synthase in the 5′-and 3′-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis. Carcinogenesis, 26: 1764–1769, 2005.
29.
GaoC.M., TakezakiT., WuJ.Z., LiuY.T., DingJ.H., LiS.P., SuP., HuX., KaiH.T., LiZ.Y., MatsuoK., HamajimaN., SugimuraH., TajimaK.: Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac J Cancer Prev, 5: 133–138, 2004.
TsukinoH., HanaokaT., OtaniT., IwasakiM., KobayashiM., HaraM., NatsukawaS., ShauraK., KoizumiY., KasugaY., TsuganeS.: hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci, 12: 977–983, 2004.
32.
YatsuyaH., ToyoshimaH., TamakoshiA., KikuchiS., TamakoshiK., KondoT., MizoueT., TokuiN., HoshiyamaY., SakataK., HayakawaN., YoshimuraT.; Japan Collaborative Cohort Study Group: Individual and joint impact of family history and Helicobacter pylori infection on the risk of stomach cancer: a nested case-control study. Br J Cancer, 91: 929–934, 2004.
33.
WuM.T., ChenM.C., WuD.C.: Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett, 205: 61–68, 2004.
34.
CaiL., ZhengZ.L., ZhangZ.F.: Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J Gastroenterol, 9: 214–218, 2003.
35.
GonzálezC.A., PeraG., AgudoA., PalliD., KroghV., VineisP., TuminoR., PanicoS., BerglundG., SimánH., NyrénO., AgrenA., MartinezC., DorronsoroM., BarricarteA., TormoM.J., QuirosJ.R., AllenN., BinghamS., DayN., MillerA., NagelG., BoeingH., OvervadK., TjonnelandA., Bueno-De-MesquitaH.B., BoshuizenH.C., PeetersP., NumansM., Clavel-ChapelonF., HelenI., AgapitosE., LundE., FaheyM., SaracciR., KaaksR., RiboliE.: Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer, 107: 629–634, 2003.
36.
MinamiY., TatenoH.: Associations between cigarette smoking and the risk of four leading cancers in Miyagi Prefecture, Japan: a multi-site case-control study. Cancer Sci, 94: 540–547, 2003.
37.
NomuraA.M., HankinJ.H., KolonelL.N., WilkensL.R., GoodmanM.T., StemmermannG.N.: Case-control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control, 14: 547–558, 2003.
38.
WuA.H., CrabtreeJ.E., BernsteinL., HawtinP., CockburnM., TsengC.C., FormanD.: Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer, 103: 815–821, 2003.
39.
WuM.S., WuC.Y., ChenC.J., LinM.T., ShunC.T., LinJ.T.: Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer, 104: 617–623, 2003.
40.
HamadaG.S., KowalskiL.P., NishimotoI.N., RodriguesJ.J., IriyaK., SasazukiS., HanaokaT., TsuganeS., São Paulo-Japan Cancer Project Gastric Cancer Study Group: Risk factors for stomach cancer in Brazil (II): a case-control study among Japanese Brazilians in São Paulo. Jpn J Clin Oncol, 32: 284–290, 2002.
41.
KikuchiS., NakajimaT., KobayashiO., YamazakiT., KikuichiM., MoriK., OuraS., WatanabeH., NagawaH., OtaniR., OkamotoN., KurosawaM., AnzaiH., KonishiT., FutagawaS., MizobuchiN., KoboriO., KaiseR., InabaY., WadaO.: U-shaped effect of drinking and linear effect of smoking on risk for stomach cancer in Japan. Jpn J Cancer Res, 93: 953–959, 2002.
42.
KimH.J., ChangW.K., KimM.K., LeeS., ChoiB.Y.: Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer, 97: 531–535, 2002.
43.
MaoY., HuJ., SemenciwR., WhiteK.: Active and passive smoking and the risk of stomach cancer, by subsite, in Canada. Eur J Cancer Prev, 11: 27–38, 2002.
44.
NishimotoI.N., HamadaG.S., KowalskiL.P., RodriguesJ.G., IriyaK., SasazukiS., HanaokaT., TsuganeS., São Paulo-Japan Cancer Project Gastric Cancer Study Group: Risk factors for stomach cancer in Brazil (I): a case-control study among non-Japanese Brazilians in Sao Paulo. Jpn J Clin Oncol, 32: 277–283, 2002.
45.
RaoD.N., GaneshB., DinshawK.A., MohandasK.M.: A case-control study of stomach cancer in Mumbai, India. Int J Cancer, 99: 727–731, 2002.
46.
CaiL., YuS.Z., ZhangZ.F.: Glutathione S-transferases M1, T1 genotypes and the risk gastric cancer: A case-control study. World J Gastroenterol, 7: 506–509, 2001.
47.
MuñozN., PlummerM., VivasJ., MorenoV., De SanjoséS., LopezG., OliverW.: A case-control study of gastric cancer in Venezuela. Int J Cancer, 93: 417–423, 2001.
48.
SimanJ.H., ForsgrenA., BerglundG., FlorenC.H.: Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals. Scand J Gastroenterol, 36: 208–213, 2001.
49.
TakezakiT., GaoC.M., WuJ.Z., DingJ.H., LiuY.T., ZhangY., LiS.P., SuP., LiuT.K., TajimaK.: Dietary protective and risk factors for esophageal and stomach cancers in a low-epidemic area for stomach cancer in Jiangsu Province, China: comparison with those in a high-epidemic area. Jpn J Cancer Res, 92: 1157–1165, 2001.
50.
KatohT., BoissyR., NagataN., KitagawaK., KurodaY., ItohH., KawamotoT., BellD.A.: Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int J Cancer, 85: 46–49, 2000.
51.
MathewA., GangadharanP., VargheseC., NairM.K.: Diet and stomach cancer: a case-control study in South India. Eur J Cancer Prev, 9: 89–97, 2000.
52.
ChowW.H., SwansonC.A., LissowskaJ., GrovesF.D., SobinL.H., Nasierowska-GuttmejerA., RadziszewskiJ., RegulaJ., HsingA.W., JagannathaS., ZatonskiW., BlotW.J.: Risk of stomach cancer in relation to consumption of cigarettes, alcohol, tea and coffee in Warsaw, Poland. Int J Cancer, 81: 871–876, 1999.
53.
GaoC.M., TakezakiT., DingJ.H., LiM.S., TajimaK.: Protective effect of allium vegetables against both esophageal and stomach cancer: a simultaneous case-referent study of a high-epidemic area in Jiangsu Province, China. Jpn J Cancer Res, 90: 614–621, 1999.
54.
HansenS., MelbyK.K., AaseS., JellumE., VollsetS.E.: Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. Scand J Gastroenterol, 34: 353–360, 1999.
55.
InoueM., TajimaK., YamamuraY., HamajimaN., HiroseK., NakamuraS., KoderaY., KitoT., TominagaS.: Influence of habitual smoking on gastric cancer by histologic subtype. Int J Cancer, 81: 39–43, 1999.
56.
ZaridzeD., BorisovaE., MaximovitchD., ChkhikvadzeV.: Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia. Int J Cancer, 82: 473–476, 1999.
57.
De StefaniE., BoffettaP., CarzoglioJ., MendilaharsuS., Deneo-PellegriniH.: Tobacco smoking and alcohol drinking as risk factors for stomach cancer: a case-control study in Uruguay. Cancer Causes Control, 9: 321–329, 1998.
58.
GammonM.D., SchoenbergJ.B., AhsanH., RischH.A., VaughanT.L., ChowW.H., RotterdamH., WestA.B., DubrowR., StanfordJ.L., MayneS.T., FarrowD.C., NiwaS., BlotW.J., Fraumeni JFJ.r.: Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst, 89: 1277–1284, 1997.
59.
ParsonnetJ., FriedmanG.D., OrentreichN., VogelmanH.: Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 40: 297–301, 1997.
60.
YeW., EkstromA.M., HanssonL.E., BergstromR., NyrenO.: Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer, 83: 223–229, 1999.
61.
DuarteM.C., ColomboJ., RossitA.R., CaetanoA., BorimA.A., WornrathD., SilvaA.E.: Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritits and gastric cancer. World J Gatroenterol, 11: 6593–6600, 2005.
62.
JiB.T., DaiQ., GaoY.T., HsingA.W., McLaughlinJ.K., FraumeniJ.F.Jr., ChowW.H.: Cigarette and alcohol consumption and the risk of colorectal cancer in Shanghai, China. Eur J Cancer Prev, 11: 237–244, 2002.
63.
La TorreG., ChiaradiaG., GianfagnaF., De LauretisA., BocciaS., RicciardiW.: Quality assessment in meta-analysis. Ital J Public Health, 3: 44–50, 2006.
64.
BalkE.M., BonisP.A., MoskowitzH., SchmidC.H., IoannidisJ.P., WangC., LauJ.: Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA, 287: 2973–2982, 2002.
65.
LiuY.X., WangJ.Z.: Meta-analysis of the relationship between smoking and stomach cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 24: 559–563, 2002.
66.
GreenlandS.: Invited commentary: a critical look at some-popular meta-analytic methods. Am J Epidemiol, 140: 290–296, 1994.
67.
PetersenM., WhiteD.: An information synthesis approach to reviewing literature. In: Health Care of the Elderly: an Information Sourcebook, PetersenM., WhiteD. (Eds), pp 26–36, Sage, Newbury Park, CA, 1989.
